OncoCyte (OCX) Reports FY Loss of $3.37

OncoCyte (NASDAQ: OCX) reported FY EPS of ($3.37). Revenue for the year came in at $1.5 million.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• HSBC Upgrades Capital One Financial (COF) to Buy
• What Delta’s report tells investors in American and United